Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1978 1
1979 1
1981 1
1982 7
1983 6
1984 4
1985 1
1986 2
1987 1
1988 1
1990 2
1993 1
1995 1
1996 1
1998 3
1999 1
2000 2
2001 1
2002 1
2003 1
2004 2
2005 1
2006 2
2008 1
2009 1
2013 1
2015 1
2017 1
2020 1
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Diflorasone.
[No authors listed] [No authors listed] 2021 Jan 18. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2021 Jan 18. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000883 Free Books & Documents. Review.
Topical diflorasone has not been studied during breastfeeding. Since only extensive application of the most potent corticosteroids may cause systemic effects in the mother, it is unlikely that short-term application of topical corticosteroids would pose a risk to the breas …
Topical diflorasone has not been studied during breastfeeding. Since only extensive application of the most potent corticosteroids ma …
Structures from powders: diflorasone diacetate.
Maccaroni E, Giovenzana GB, Palmisano G, Botta D, Volante P, Masciocchi N. Maccaroni E, et al. Steroids. 2009 Jan;74(1):102-11. doi: 10.1016/j.steroids.2008.09.014. Epub 2008 Oct 18. Steroids. 2009. PMID: 19013475
Diflorasone diacetate, a steroid anti-inflammatory drug (marketed as Diacort or Florone by Pfizer) and used in the treatment of skin disorders, can be prepared as anhydrous form, DD1 (as deposited in the US pharmacopoeia), or as a monohydrated phase, DDW. ...
Diflorasone diacetate, a steroid anti-inflammatory drug (marketed as Diacort or Florone by Pfizer) and used in the treatment o …
Diflorasone diacetate: vasoconstrictor activity and clinical efficacy of a new topical corticosteroid.
Bluefarb SM, Howard FM, Leibsohn E, Schlagel CA, Wexler L. Bluefarb SM, et al. J Int Med Res. 1976;4(6):454-61. doi: 10.1177/030006057600400613. J Int Med Res. 1976. PMID: 800385 Clinical Trial.
Diflorasone diacetate, a new topical corticosteroid, was generally more potent than three high potency reference standards (fluocinonide, beta-methasone 17-valerate and fluocinolone acetonide) when the compounds were dissolved in 95% alcohol and applied in vasoconst …
Diflorasone diacetate, a new topical corticosteroid, was generally more potent than three high potency reference standards (fl …
Drugs for atopic dermatitis.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2020 Jun 15;62(1600):89-96. Med Lett Drugs Ther. 2020. PMID: 32555122 No abstract available.
Comparative efficacy of once a day diflorasone diacetate and twice a day betamethasone valerate ointment applications in eczematous dermatitis.
Johansson EA, Stiger TR. Johansson EA, et al. Curr Med Res Opin. 1984;9(4):259-64. doi: 10.1185/03007998409109589. Curr Med Res Opin. 1984. PMID: 6510015 Clinical Trial.
The efficacy of once a day applications of 0.05% diflorasone diacetate ointment and twice a day applications of 0.1% betamethasone valerate ointment was compared in 70 patients with eczematous dermatitis. ...At Week 3, this difference in the improvement of pruritus …
The efficacy of once a day applications of 0.05% diflorasone diacetate ointment and twice a day applications of 0.1% betametha …
Diflorasone diacetate ointment 0.05% versus betamethasone dipropionate ointment 0.05% in moderate-severe plaque-type psoriasis.
Shupack JL, Jondreau L, Kenny C, Stiller MJ. Shupack JL, et al. Dermatology. 1993;186(2):129-32. doi: 10.1159/000247323. Dermatology. 1993. PMID: 8428041 Clinical Trial.
We report the results of a 2-week double-blind, parallel clinical trial comparing two superpotent topical glucocorticosteroid ointments, diflorasone diacetate 0.05% and betamethasone dipropionate 0.05%, in psoriatic adults. ...
We report the results of a 2-week double-blind, parallel clinical trial comparing two superpotent topical glucocorticosteroid ointments, …
Effects of polyoxypropylene 15 stearyl ether and propylene glycol on percutaneous penetration rate of diflorasone diacetate.
Turi JS, Danielson D, Woltersom JW. Turi JS, et al. J Pharm Sci. 1979 Mar;68(3):275-80. doi: 10.1002/jps.2600680306. J Pharm Sci. 1979. PMID: 423113
Theoretical models for percutaneous penetration are described, and a diffusion apparatus useful in the evaluation of transport kinetics of drugs applied to skin is discussed. Experimental data are presented for: (a) the flux of diflorasone diacetate through hairless …
Theoretical models for percutaneous penetration are described, and a diffusion apparatus useful in the evaluation of transport kinetics of d …
Comparative efficacy of once-daily flurandrenolide tape versus twice-daily diflorasone diacetate ointment in the treatment of psoriasis.
Krueger GG, O'Reilly MA, Weidner M, Dromgoole SH, Killey FP. Krueger GG, et al. J Am Acad Dermatol. 1998 Feb;38(2 Pt 1):186-90. doi: 10.1016/s0190-9622(98)70238-5. J Am Acad Dermatol. 1998. PMID: 9486672 Clinical Trial.
OBJECTIVE: Our purpose was to determine the relative efficacy of flurandrenolide (4 microg/cm2) tape versus 0.05% diflorasone diacetate ointment in plaque psoriasis. METHODS: Thirty patients participated in an investigator-blinded, randomized, bilateral paired-compa …
OBJECTIVE: Our purpose was to determine the relative efficacy of flurandrenolide (4 microg/cm2) tape versus 0.05% diflorasone diac …
Diflorasone diacetate ointment 0.05 percent in conjunction with UVB and tar in a modified outpatient Goeckerman regimen.
Spencer SA, Fenske NA, Bookbinder SA, Vasey FB. Spencer SA, et al. Cutis. 1985 Aug;36(2):169-72. Cutis. 1985. PMID: 4028832
Treatment consisted of daily coal tar emulsion baths at bedtime, followed by the application of 0.05 percent diflorasone diacetate ointment. Patients received increasing suberythemal dosages of short ultraviolet radiation (UVB) three times weekly at our outpatient p …
Treatment consisted of daily coal tar emulsion baths at bedtime, followed by the application of 0.05 percent diflorasone diacetate …
51 results